stockrowHyperfine, Inc. (HYPR) vs Nyxoah SA (NYXH)
- Hyperfine, Inc. HYPR 0.70 +1.45%
- Nyxoah SA NYXH 0.81 0.00%
Hyperfine, Inc. and Nyxoah SA are both Medical Devices companies. Nyxoah SA is the larger, with a market value of $82.6M against $72.7M — 1.1× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 53.2%. Hyperfine, Inc. has the higher net margin (−210.8% vs −446.4%) and the lower return on invested capital (−401.8% vs −117.8%). Across the 18 metrics below, Hyperfine, Inc. leads on 10 and Nyxoah SA on 8.
Valuation
Profitability
| Metric | HYPR | NYXH | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | 60.16% | 57.76% |
| Operating margin | (203.27%) | (391.25%) | (15.07%) |
| Net margin | (210.75%) | (446.39%) | (14.45%) |
| Free cash flow margin | (166.48%) | (344.99%) | (3.88%) |
| Return on equity | (96.97%) | (124.41%) | (10.35%) |
| Return on assets | (64.40%) | (68.23%) | (17.26%) |
| Return on invested capital | (401.79%) | (117.82%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack